+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Response of the spleen of Balb/c and p53-transgenic mice to low doses of carcinogen and to polyclonal antibodies generated against the soluble 53 kDa protein



Response of the spleen of Balb/c and p53-transgenic mice to low doses of carcinogen and to polyclonal antibodies generated against the soluble 53 kDa protein



Anticancer Research 20(1a): 385-390



Background: We have previously reported that p53-transgenic mice are highly sensitive to low doses of a carcinogen and to vaccination with soluble 53kDa antibodies, compared to normal mice. The splenic manifestation of this strain dependent hypersensitivity was investigated immunohistochemically and morphometrically. Methods: The spleen was obtained from Balb/c and human p53 promoter-CAT transgenic mice. Mice had either been treated with the carcinogen dimethylhydrazine (DMH), vaccinated before DMH treatment with polyclonal IgG generated against the soluble 53 kDa protein, or left untreated. Results: Significant differences in the splenic structures were found between the strains compared, including the area occupied by the white and red pulps, the periarterial lymphoid sheath (PALS) and the marginal zone, and in the number of lymphoblasts and lymphocytes. Exposure to DMH stimulated the immune response, but in transgenic mice the number of B and T lymphocytes and especially helper T lymphocytes was significantly lower than in Balb/c mice. Vaccination followed by DMH injections did not improve the insufficiency of the immune response in transgenic mice. In transgenic mice, the number of B lymphocytes in follicles was almost half and the total number of cells in PALS and the number of T lymphocytes were only 71% and 60% respectively in BALB/c mice. In the marginal zone, macrophages proliferated as lymphocytes decreased. Conclusions: Insufficiency of the immune system after exposure to a carcinogen is more pronounced in transgenic mice, and is mainly related to the B-cell system. It may stem from defects in B lymphocytes or from inherent differences in their maturation and regulation. The increase in the number of macrophages, dendritic cells and neutrophils illustrates the compensatory processes that can remedy this developing immune insufficiency.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011292850

Download citation: RISBibTeXText

PMID: 10769684


Related references

Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies. Anticancer Research 18(1a): 273-281, 1998

Effects of low doses of carcinogen and different antibodies on the splenic lymphoid system of p53 transgenic mice: morphometric and immunohistochemical studies. International Journal of Molecular Medicine 4(2): 197-202, 1999

Comparative mitogenicity and polyclonal b cell activation capacity of eight oral or nonoral bacterial lipopolysaccharides in cultures of spleen cells from athymic nu nu balb c and thymic balb c mice. Oral Microbiology & Immunology 7(2): 71-77, 1992

Polyclonal B cell activation by cell wall preparations of gram-positive bacteria. In vitro responses of spleen cells obtained from Balb/c, nu/nu, nu/+, C3H/He, C3H/HeJ and hybrid (DBA/N x Balb/c)F1 mice. Microbiology and Immunology 24(3): 209-218, 1980

In vitro proliferative response and polyclonal antibody production in spleen cells of immunologically defective CBA/N and C3H/HeJ mice by water-soluble adjuvant (Bu-WSA) extracted from Bacterionema matruchotii. Microbiology and Immunology 25(11): 1139-1149, 1981

Characterization of the cellular response of spleen cells in BALB/c mice inoculated with Mycoplasma pneumoniae or the P1 protein. Medical Microbiology & Immunology. 182(2): 77-85, 1993

CD14 transgenic mice expressing membrane and soluble forms: comparisons of levels of cytokines and lethalities in response to lipopolysaccharide between transgenic and non-transgenic mice. International Immunology 11(3): 333-339, 1999

Specific polyclonal antibodies to a mouse liver carcinogen binding protein. Federation Proceedings 46(6): 2254, 1987

Transplacental tumor-preventive effects of polyclonal antibodies generated against the soluble 53 kDa antigen on mammary tumorigenesis in offspring. Oncology Reports 6(4): 897-900, 1999

The immune response of rat spleen to dietary fibers and to low doses of carcinogen: morphometric and immunohistochemical studies. Oncology Reports 5(6): 1577-1581, 1998

Antibodies generated against human zona pellucida protein 1 expressed in the ovaries of transgenic mice inhibit homologous sperm binding in the mouse. Molecular Biology of the Cell 10(Suppl. ): 358a, 1999

Polyreactive binding of antibodies generated by polyclonal B cell activation. II. Crossreactive and monospecific antibodies can be generated from an identical Ig rearrangement by differential glycosylation. Scandinavian Journal of Immunology 45(3): 240-247, 1997

Cytokine profiles of cervical lymph nodes and spleen in Balb/c mice microinfused into CSF with soluble recombinant HIV p24. FASEB Journal 12(5): A880, 1998

Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain. International Immunology 19(12): 1395-1402, 2007

Enhanced sensitivity of DEAE-dextran treated spleen cells from normal BALB/C mice, B-lymphocyte depleted BALB/C mice and nude mice to in vitro antibody-complement mediated immune cytolysis. Medical Microbiology and Immunology 160(4): 251-256, 1974